G ENETIC and physiological studies show that cell
proliferation by the budding yeast Saccharomyces cerevisiae is regulated in the pre-replicative interval of the cell cycle (PRINGLE and HARTWELL 198 1 ; WHEALS 1987) ; this regulatory step has been termed start (HARTWELL 1974). The performance of start, and thus the proliferation of yeast cells, is responsive to the biosynthetic status of the cell ( WHEALS 1987) . Indeed, the initiation of a new round of cell division is correlated with growth of a cell to what can be measured as a threshold cell size (the "critical size"; JOHNSTON, PRINGLE and HARTWELL 1977) . Furthermore, limitation of biosynthesis by starvation for certain required nutrients can prevent the performance of start and bring about a regulated cessation of proliferation with cells arrested at start (HARTWELL 1974; JOHNSTON, PRINGLE and HARTWELL 1977; PRINGLE and HARTWELL 1981) . In addition to this form of start regulation, particular effector molecules such as yeast mating pheromones can modulate start independently of biosynthetic activity (BUCKING- THROM et al. 1973) .
The control of yeast cell proliferation has been analyzed genetically, in part through the identification of conditional mutations that inhibit the performance of start (HARTWELL 1974; PRINGLE and HARTWELL 1981; WHEALS 1987) . Under nonpermissive conditions cells harboring these mutations complete an ongoing cell-division cycle but are unable to initiate a
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Genetics 124: 81-90 (January. 1990) new cell cycle, and thus accumulate at the regulatory step start. These start mutations have been grouped into two categories: mutations that bring about arrest of cell proliferation at start most likely as a secondary consequence of impairment of certain biosynthetic activities, and other mutations that have little effect on biosynthetic activity (REED 1980). Some start mutations of the latter type have been found to affect the pheromone response pathway, or components of the cell-cycle regulatory mechanism itself. For example, mutations in the GPAl gene, encoding the cy subunit of a yeast G protein that is a transducer of the mating pheromone response, cause start arrest U A H~G , FER- GUSON and REED 1988) . Other start mutations in this category affect the CDC28 gene product, a protein kinase (LORINCZ and REED 1984) that is part of a highmolecular-weight complex required to initiate a new cell cycle ( WITTENBERG and REED 1988) . Certain other mutations of this type that affect start have been identified in a directed way, based on interactions with previously characterized genes ( HADWIGER et al. 1989; REED et al. 1988) ; in some cases the products of the genes harboring these mutations have been shown to interact (HADWIGER et al. 1989) . These genes and others known to affect start probably encode only a subset of the components involved in start regulation. It should therefore be profitable to extend the search for mutations that influence start without significant inhibition of biosynthetic activity.
The responsiveness of proliferation control to biosynthetic activity suggests that new start mutations sought without consideration of this particular rela-tionship will in most instances affect biosynthetic activities that influence start, rather than components of the start regulatory apparatus (see WHEALS 1987) . However, all mutations that differentially inhibit the performance of start (primarily or only secondarily) produce the same basic phenotype: mutant cells accumulate at start, in the unbudded phase of the yeast cell cycle. Therefore other criteria, most notably the necessity for start-arrested mutant cells to undergo growth-related activities such as conjugation, have been used to identify interesting start mutations (REED 1980).
Here we describe the isolation and characterization of new start mutations that cause arrest of cell proliferation but still allow significant biosynthetic activity to continue. This work relied on a selection scheme designed to enrich for mutant cells that become enlarged and thus continue biosynthetic activity upon incubation at the nonpermissive temperature. Genetic mapping and molecular cloning indicate that the new mutations reported here define two previously unidentified genes, and show that a third gene harbors start mutations. Therefore three previously unsuspected genes are shown to affect start. Perhaps more significantly, the procedures used here identified mutations in known cdc genes but did not yield new mutations in well-known start genes, suggesting that the catalog of genes that function primarily to affect start may be large.
MATERIALS AND METHODS

Strains and growth media:
T h e haploid strain GR2 (MATa his6 ural) has been described (JOHNSTON and SINGER 1978) . Strain 21R (MATa adel leu2-3,112 ura3-52; JOHN-STON and HOPPER 1982) was obtained from J. E. HOPPER and used to construct transformable strains. Strain Sc25k-13 (MATa adel leu2-3,112 ura3-52 KEX1::LEUZ; DMO-CHOWSKA et al. 1987) was used for genetic mapping. Strain XJB3-1B (MATa met6) was the MATa tester strain, and strains 47S-104A (MATa cdc64-1 leul) and 47s-7 (MATa cdc62-1) (BEDARD, JOHNSTON and SINGER 1981) were reference strains in quantitative mating reactions (BEDARD, JOHNSTON and SINGER 1981; BEDARD et al. 1984) . Yeast cells were routinely grown in YM1 complex medium (HART-WELL 1967) or YNB minimal medium (JOHNSTON, PRINGLE and HARTWELL 1977) . Similar solid complex (YEPD) or synthetic media (HARTWELL 1967) were also used. Escherichia coli strain RR1 was obtained from J. E. HOPPER and used for plasmid isolation and maintenance. E. coli cells were grown in Y T medium (MILLER 1972) .
Assessment of cellular parameters: Yeast cell concentrations were determined using an electronic particle counter (Coulter Electronics, Hialeah, Florida). Before counting, cells were fixed using formalin and sonicated briefly (HART-WELL 1970) . Cell morphology was assessed by direct microscopic examination. Rates of protein and RNA synthesis were estimated by a pulse-labeling procedure described previously (HANIC~OYCE, JOHNSTON and SINGER 1987) . DNA content was quantified by a modified diphenylamine procedure as described (STORMS et al. 1984) .
Mutant isolation: Stationary-phase cells of strain GR2
were mutagenized by exposure to ethylmethane sulfonate (EMS, 1:20; Sigma) for 3 hr (Fink 1970) to yield 10-50% survival, then diluted 60-fold into replicate volumes of YM 1 liquid medium and grown to stationary phase at 23". For mutant enrichment these stationary-phase cultures were first diluted into fresh YM1 medium and incubated at 23"; the resulting exponential-phase cultures were then transferred to 36" and incubated for 3 hr. Reconstruction experiments using strains bearing previously characterized start mutations showed that this incubation time was long enough to allow temperature-sensitive start mutants to arrest cell division and grow significantly, but short enough to avoid the loss of cell viability characteristic of many mutants incubated for prolonged periods under nonpermissive conditions (see BEDARD, JOHNSTON and SINGER 198 1) . Cells were then harvested by centrifugation, washed once with phosphate buffer, and sonicated briefly to separate cells; a concentrated suspension of 10' of these cells was layered onto 10 ml of a colloidal suspension of glass beads, prepared by diluting Ludox HS30 (DuPont), a 30% suspension of colloidal glass beads, to 17% with 0.1 X YNB medium, adjusting to pH 8.0, and autoclaving. This suspension forms a gradient upon centrifugation (SHULMAN, HARTWELL and WARNER 1973) , and after centrifugation at 42,000 X g for 10 min most of the cells had migrated sufficiently far into the tube to form a wide band about 1.5 cm from the bottom of the 10-cm tube. Cells were not centrifuged to their equilibrium density. With a U-shaped Pasteur pipette, samples of the gradient were removed from the area above the main band of cells, diluted and spread on YEPD solid medium. Replicas of the resultant colonies were incubated on YEPD medium at 23" and at 36" to identify colonies of temperature-sensitive cells. Genetic analysis: Mutant isolates were analyzed by standard genetic procedures (MORTIMER and SCHILD 198 1) . Noncomplementation of new recessive temperature-sensitive mutations was verified by temperature sensitivity, on solid medium, of diploids selected by complementation of auxotrophies.
Mating assay: Conjugation by arrested mutant cells was assessed as described (BEDARD et al. 1984) . In brief, actively dividing MATa mutant cells were transferred from 23" to 36" and incubated for 3.5 hr. These cells were then mixed with an equal number of cells of tester strain XJBJ-lB, the cell mixture was collected on a nitrocellulose filter, and the filter disc bearing the cells was incubated on YEPD medium for a further 3 hr at 34". These cells were then suspended in YMl medium and immediately spread on solid selective medium to select for diploids on the basis of complemented auxotrophies. For comparison, the mating-proficient startmutant strain 478-7 and the mating-incompetent start-mutant strain 47s-104A were included in mating experiments. T o ensure that mutant cells had remained viable during the incubations at nonpermissive temperatures, the number of viable mutant cells within the mating mixture also was assessed after plating the mating mixture on medium that would select against growth of the tester strain. Mating was also quantified with all incubations at 23 O .
Molecular cloning: Genes identified by mutation were cloned by complementation (ROTHSTEIN 1986; ROSE 1987) . For transformation, mutant strains were twice backcrossed to a transformable strain. In all cases, 10-30 pg of yeast genomic library DNA were used to transform mutant cells to both temperature resistance and uracil prototrophy by the method of HINNEN, HICKS and FINK (1978) . The YEp24-based library R114 was kindly provided by D. BOTSTEIN. Restriction analysis was performed as described (MANIATIS, FRITSCH and SAMBROOK 1982) . Probes were prepared using a Random Primed DNA Labelling Kit (Boehringer Mann-heim) and ["PIATP, a gift from J. HOFMAN (Department of Biochemistry, Dalhousie University). Chromosomal assignments of cloned sequences were determined by hybridization to blots of intact yeast chromosomes separated by CHEF (contour-clamped homogeneous electric field) electrophoresis (CHU, VOLLRATH and DAVIS 1986 ) and transferred to Genescreen membranes (New England Nuclear) by L. SCHALKWYK (Department of Biochemistry, Dalhousie University), using the method of REED and MANN (1985) . Southern analyses were performed as described (MANIATIS, FRITSCH and SAMBROOK 1982) .
Construction of integration plasmids: T o integrate the cloned CDC65 insert, a BamHI fragment was first removed from the complementing insert sequence in plasmid pLE9-3 (Figure 3 For the CDC67 gene a 2-kb Hind111 fragment from the insert in p67-13E ( Figure 3 ) was subcloned into YIp5, and homologous integration of this plasmid into cdc67-1 haploid cells was directed by cleavage within the insert sequence using XbaI, and confirmed by Southern analysis (Figure 3) . Analysis of 19 tetrads demonstrated that the plasmid-borne URA3 gene co-segregated with the cdc67-1 mutation.
For the cloned CDC68 gene, a 1.7-kb Hind111 fragment from the insert of plasmid pSC2-I was subcloned into YIp5. This plasmid was integrated into the chromosome of haploid cdc68-1 cells, and shown by Southern analysis to be integrated at the insert locus ( Figure 3 ). Analysis of 26 tetrads showed cosegregation of the plasmid-borne URA3 gene and the cdc68-1 mutation. This protocol allowed the enlargement through continuing biosynthetic activity of the rare mutant cells that continue to grow when blocked in cell division at the nonpermissive temperature. These cell suspensions were then resolved by centrifugation through colloidal glass beads to separate cells by size. After centrifugation, the cells in regions of the centrifuge tube expected to contain larger-than-normal cells were tested for temperature sensitivity by replica plating and by growth in liquid medium, and assessed for phenotype. In separate experiments cdc mutant cells were mixed 1: 1000 with wild-type cells of strain GR2 and centrifuged through colloidal glass beads as described in MATERIALS AND METHODS. Following centrifugation three adjacent 1-ml fractions were removed from above the main band of cells, with fraction C the one nearest to the main band. The proportion of temperature-sensitive cells in each fraction was determined by replica-plating procedures, and expressed relative to the input proportion as the enrichment factor.
RESULTS
Mutant isolation:
T h e efficacy of this centrifugation method for mutant isolation was determined by reconstruction experiments. Suspensions of wild-type cells were seeded with small numbers of cells harboring previously characterized cdc mutations, and subjected to the enrichment procedure. As shown in Table 1 Genetic analysis: Interesting mutants with uniform terminal morphologies at the nonpermissive temperature were subjected to genetic analysis. In several isolates more than one temperature-sensitive mutation was present; in some cases each of these mutations individually produced only a random arrest in the cell cycle as judged by cell morphology. Genetic segregants containing only a single recessive mutation producing a common terminal phenotype were chosen for further study.
Single mutations producing cdc phenotypes were tested by complementation against other recessive temperature-sensitive mutations, including cdc mutations. Included in these tests were strains bearing mutations in the CDCI-CDC37, CDC39, CDC46, CDC47 (PRINGLE and HARTWELL 198 1 ; WHEALS 1987) , and the CDC60, CDC62, CDC64
(BEDARD, JOHNSTON and SINGER 198 1) and CDC63 (PRTI; HANIC-JOYCE 1985; HANIC-JOYCE, SINGER and JOHN-STON 1987) genes. Also included in the complementation analysis were mutations in other genes producing cdc phenotypes, such as DBFI-DBF4, DBF6, DBF7, and DBF9 (JOHNSTON and THOMAS 1982) , in genes differentially affecting DNA metabolism, such as DDSI-DDS6 (JOHNSTON and GAME 1978) and DNAI-DNA60 (DUMAS et al. 1982) , and in genes differentially affecting RNA metabolism, such as RNAI-RNA9 and RNA1 I (HARTWELL, MCLAUGHLIN and WARNER 1970) . As shown in Table 2 , these complementation tests indicated that some of the newly isolated temperature-sensitive mutations were new alleles of previously identified complementation groups.
The isolation by this procedure of new mutations in certain previously identified genes (Table 2) verified the efficacy of the isolation procedure. For example, new mutations were readily obtained in the CDC14 and CDC24 genes; previously characterized mutations in each of these genes allow significant cell enlargement at the nonpermissive temperature (JOHNSTON, PRINGLE and HARTWELL 1977) . New mutations were also obtained in three DNA genes; these a DNA content, measured spectrophotometrically as described in Materials and Methods, was determined at the time of transfer (0 h) and after 6 h incubation of mutant cells at the nonpermissive temperature.
The average DNA content of cells after arrest of proliferation (6 h), divided by the average DNA content of proliferating cells (0 h). Because individual cells in a GI-arrested population have an unreplicated complement of DNA, while individual cells in a proliferating population have DNA contents that range from an unduplicated to a fully duplicated complement of DNA, the relative DNA content of GI-arrested cells expressed in this way should be less than 1 .O.
' This cdc65-I mutant is a homozygous diploid. For comparison, a previously characterized GI-arrest mutant (cdc35-I; PRINGLE and HARTWELL 1981) was also analyzed. genes were originally identified by mutations that inhibit DNA synthesis more severely than the accumulation of cell mass (DUMAS et al. 1982), and would thus be expected to allow significant cell enlargement at the mutationally induced block. Moreover, the cdc phenotypes produced by the new mutations in these DNA genes show that these genes may have specific effects on the cell cycle.
Several new mutations produced an unbudded phenotype characteristic of start mutations ( Table 2) . One of these mutations was allelic with cdc60-I, previously shown to block start (BEDARD, JOHNSTON and SINGER 1981) . This mutation was not characterized further. A second new mutation, cdc65-I, was allelic with dna33, a mutation that had been shown to affect DNA replication but that had not been characterized for effects on the cell cycle (DUMAS et al. 1982) . Finally, three of the new mutations complemented every tester mutation, and thus defined the genes CDC66, CDC67, and CDC68. Each of these three new mutations, plus cdc65-1, caused cells at the nonpermissive temperature of 36 O to arrest proliferation within one cell cycle. In each arrested population 80-90% of cells were unbudded, suggesting that the arrested cells were in the G1 (prereplicative) interval of the cell cycle (HARTWELL 1974) . The DNA contents of arrested cells confirmed G1 arrest for cdc65-I, cdc67-1, and cdc68-1 mutant cells (Table 3 ). This G1 arrest was not accompanied by significant cell deformation (data not shown).
The cdc66-I mutation produces an unusual type of arrest, and will be the subject of another report.
Start arrest: Unbudded G1 arrest suggested that each of these new mutations inhibited the performance of start. To ascertain the relationship between The results of an order-of-function experiment for the cdc65-1 mutation are shown in Figure 1 . Mutant cells of mating type a (requisite for a-factor sensitivity) were first arrested at start at the permissive temperature by treatment with a-factor (Figure 1, A and C) . Further incubation in fresh medium without a-factor but at the nonpermissive temperature of 36 O resulted in no change in the proportion of unbudded cells and no cell division, indicating that cells arrested in the cell cycle by mutation were blocked at or after the afactor-sensitive step. In the reciprocal experiment ( Figure 1, B and D) , mutant cells were first arrested at the temperature-sensitive block by incubation for 2.5 hr at 36". Further incubation of these cells at the permissive temperature but in the presence of a-factor also resulted in no change in the proportion of unbudded cells and no cell division, indicating that cells arrested by the mutation were blocked at or before the a-factor-sensitive step. Taken together these reciprocal-shift experiments indicate that the cdc65-1 mutation blocks cells at a step interdependent with the a-factor-sensitive step; by this criterion the cdc65-I mutant cells arrest at start.
Similar results from reciprocal-shift experiments were obtained for strains harboring the cdc67-I and cdc68-I mutations (data not shown). Thus each of these new mutations arrests cells at start.
The start-arrest phenotype for cdc65-I mutant cells suggested that the allelic dna33 mutation, character-FIGURE 1 .-Order-of-function analysis relating start and the cdc65-1 block point. Panels A and C: mutant cells proliferating at 23" were exposed to a-factor for 3 hr, then transferred to medium without a-factor and incubated at 23" to test for recovery from a-factor treatment, or at 36" to test for cell division in the presence of the cdc65-I block. Panels B and D: mutant cells proliferating at 23" were transferred to 36" and incubated 2.5 hr, then returned to 23" and incubated to test for recovery from the temperature-induced block, or returned to 23" and incubated along with a-factor to test for cell division in the presence of that start inhibitor. Symbols: A, cells at 23"; 0, cells at 36"; 0, cells at 23" in the presence of a-factor.
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ized only to prevent continued DNA replication (Du-MAS et al. 1982), probably affected DNA replication by blockage of start, an event required for initiation of DNA synthesis (HEREFORD and HARTWELL 1974) . In fact the dna33 mutation, backcrossed into the GR2 genetic background, produced a modest (70%) unbudded-cell arrest upon transfer to 36" (data not shown). It is thus more informative to continue to refer to our new start mutation as cdc65-1, and to the allelic dna33 mutation as cdc65-33.
Biosynthetic activity in arrested mutant cells: The mutant-isolation scheme used here was designed to enrich for enlarged cells. Each of the mutations did, in fact, lead to large unbudded cells (data not shown), and to marked cell enlargement (turbidity per cell) at the nonpermissive temperature (Figure 2, A, B , and C). T o determine the effects of each start mutation on biosynthetic activity more directly, rates of protein and RNA synthesis were determined by pulse-labeling procedures. The rates of incorporation of radiolabeled precursors for protein and RNA by mutant cells were then normalized to the incorporation rates exhibited by related wild-type cells under the same conditions. In this way the effects on biosynthetic activity of a particular mutation could be distinguished from other effects on label incorporation caused by transfer to the nonpermissive temperature (HANIC-JOYCE, JOHNSTON and SINGER 1987) . As shown in Figure 2 , D, E, and F, each of the new start mutations permitted significant rates of incorporation upon transfer to the nonpermissive temperature. The cdc65-I mutation caused the greatest impairment of continued biosynthetic activity, but even these mutant cells maintained 20-40% of the control rate of precursor incorpora- Conjugation by arrested mutant cells: Some mutant cells that arrest at start and maintain biosynthetic activity also retain the ability to undergo conjugation in the arrested state (REED 1980). This criterion of mating competence was applied to mutant strains harboring the new start mutations described here. A standard mating assay (BEDARD et al. 1984) was used to quantify the mating efficiencies of arrested mutant cells, as normalized to that of the related wildtype strain GR2; for comparison, previously characterized mating-proficient and mating-incompetent mutant strains were similarly tested (Table 4 ). The cdc68-1 mutant strain remained competent to conjugate and in fact was as proficient in this mating assay as a cdc28-4 mutant strain similarly tested (BEDARD et al. 1984) . Strains bearing the cdc65-1 or cdc67-1 mutation, otherwise competent in mating at the permissive temperature of 23 O (data not shown), lost mating ability under start-arrest conditions (Table 4) . Furthermore, in mating mixtures containing these mutant cells an intermediate step in conjugation, that of zygote formation, was also impaired (Table 4) . This finding distinguishes the mating deficiencies caused by the cdc65-I and cdc67-1 start mutations from the karyogamy defects caused by certain other start mutations (DUTCHER and HARTWELL 1982), and suggests that the mating defects in these cdc mutant cells occur early in the pathway of response to mating pheromones. Matings were performed as described in MATERIALS AND METH-ODS. All strains were equally competent in diploid formation at 23" (data not shown).
a T h e efficiency of diploid formation by wild-type cells treated by the same temperature regime was set to 100%. No loss of viability occurred for any strain during the time course of the experiment (data not shown).
' Zygotes at the time of plating for diploids (approximately 400 cells scored per observation). Zygote and mating data derive from separate experiments. ND, not determined.
Cloning the new CDC genes: Yeast genomic sequences that complemented the temperature-sensitive defects in cdc65-1, cdc67-1 and cdc68-1 mutant strains were isolated from a yeast genomic DNA library (Figure 3) . For two of the three mutations, independent temperature-resistant transformants were found by restriction mapping to contain recombinant plasmids with overlapping yeast genomic inserts, suggesting that in each of these cdc mutant recipient strains the same complementing sequence had been isolated repeatedly; one member of each group of related plasmids complementing a cdc mutation was chosen for The two different sequences that relieve the temperature sensitivity of cdc65-I are both shown; in the other cases only one of the overlapping inserts is shown. To the right of each restriction map is a Southern analysis (see MATERIALS AND METHODS) of genomic DNA isolated from untransformed (U) and transformed (T) cells, confirming directed integration (4) of each cloned sequence at the homologous chromosomal locus (a). For the CDC65 integrant, XhoIdigested DNA was probed with a 6-kb EcoR1 fragment from the integration plasmid that contained insert and vector sequences but not the URA3 gene. For the SCC65 integrant, DNA digested with SstI and XhoI was probed with the integration plasmid, including the URA3 gene. For the CDC67 integrant, BglIIdigested DNA was probed with the same 2-kb Hind111 fragment used to construct the integration vector (Figure 3 ; see MATERIALS AND METHODS). For the CDC68 integrant, Southern blots of KpnIdigested DNA were probed with the integration plasmid. The restriction fragment containing the ura3-52 locus is thus also shown in the blots for SCC65 and CDC68. further study. In each case, loss of the plasmid vector marker URA3 resulted in concomitant loss of temperature resistance, while retransformation of the cdc mutant strain with the purified plasmid restored temperature resistance, thus confirming complementation of the cdc mutation by the genomic insert.
Plasmid derivatives were integrated (ORR-WEAVER, SZOSTAK and ROTHSTEIN 198 1) into the yeast genome at the site of insert homology (see MATERIALS AND METHODS), and confirmed by Southern analysis (Figure 3) . Genetic analysis of mutant strains containing these integrated plasmids showed tight linkage of the vector marker URA3 to the temperature-sensitive mutation (see MATERIALS AND METHODS), indicating that the plasmid had integrated by homologous recombination at the cdc locus and providing strong evidence that the genomic insert contained the CDC gene.
Transformation of the cdc65-1 mutant strain yielded two different genomic sequences that made mutant cells temperature-resistant upon retransformation. This finding suggested that at least one of these inserts contains a heterologous sequence that suppresses the cdc65-1 defect, rather than supplying wild-type CDC65 function. Plasmid-integration analysis (Figure 3) showed that the cdc65-1 mutation is tightly linked to the genomic sequence cloned within plasmid pLE9-3 (Figure 3 ), suggesting that this plasmid contains the wild-type CDC65 gene. Integration of the other cloned sequence by homologous recombination within the insert (Figure 3 ) did not yield genetic linkage between cdc65-1 and the integrated vector marker (see MATERIALS AND METHODS), showing that the genomic insert in plasmid pLE3-3 contains an unlinked suppressor sequence. Furthermore, the suppressor sequence subcloned into the centromerecontaining shuttle vector YCp50 (Rose 1987) did not suppress the temperature sensitivity of the transformed cdc65-1 mutant (data not shown), showing that suppression is a function of increased gene dosage, and perhaps of overexpression. The suppressor gene within the cloned genomic insert of plasmid pLE3-3 has been named SCC65.
Transformation of a cdc65-33 (dna33) mutant strain with the episomal plasmid pLE9-3 produced temperature-resistant transformants that concomitantly lost temperature resistance when the URA3 marker was lost. These transformation results are consistent with the allelic nature of the two cdc65 mutations. More interestingly, transformation of the same cdc65-33 strain with the episomal suppressor plasmid pLE3-3 also gave rise to temperature-resistant transformants that showed concomitant loss of the URA3 vector marker and of temperature resistance. Suppression by the SCC65 sequences on plasmid pLE3-3 is thus not allele-specific.
Genetic mapping: The genetic map position of the cdc65-1 mutation was previously shown by a chromosome-loss procedure to be on the right arm of chromosome X l I l , between rnal and adel (HANIC-JOYCE 1985; Table 5 ). In these earlier mapping studies the cdc65-1 mutation was erroneously designated cdc61-1. The cdc61 designation has been removed from the yeast genetic map (D. SCHILD, personal communication).
To determine the genetic map positions of the remaining new cdc mutations and of the cdc65 suppressor sequence SCC65, the cloned sequences were used to identify the yeast chromosome of origin. Each recombinant plasmid hybridized to two different chromosomes that had been resolved electrophoretically: one of these was chromosome V , probed by the URA3 sequences on the plasmid vector, and the other was the chromosome bearing the sequence of interest (Figure 4 , and data not shown). For example, Figure  4 shows that the SCC65 suppressor sequence is derived from chromosome XII. Similar blots localized CDC67 on chromosome XVI and CDC68 on chromosome VII (data not shown). Tetrad analysis then positioned the mutation marking each of the CDC genes ( Table 5) . As suggested by the complementation results above, none of the cdc mutations mapped to a previously known gene (MORTIMER and SCHILD 1985) .
DISCUSSION
Using a novel selection procedure based on cell enlargement, we have identified new mutations that arrest yeast cell proliferation in uniform fashion. Three of these mutations are of particular interest here. These mutations differentially block the performance of start, and define several previously unidentified genes.
The procedure used here was based on observations that many cdc mutants, including some start mutants, continue biosynthetic activity when blocked in proliferation (JOHNSTON, PRINCLE and HARTWELL 1977) . Thus it was expected that some of the temperaturesensitive mutants identified through the enrichment procedure for enlarged cells described here would express a cdc phenotype, and furthermore that many of these cdc mutants would be blocked at start without significant impairment in biosynthetic activity. These expectations were realized (Table 2; Figure 2 ).
The previous isolations of start mutations have in many cases been facilitated by different enrichment procedures that exploit various properties of start mutant strains (see WHEALS 1987) . For example, the ability of cdc28 mutant cells to undergo conjugation upon arrest at start dictated the scheme that was used to isolate start mutations in the CDC36, CDC37 and CDC39 genes, as well as more cdc28 mutations (REED 1980) . By a different selection scheme, new mutations in the CYRl (CDC35) gene and in four other genes were identified based on the biosynthetic defects they produced (BOUTELET, PETITJEAN and HILGER 1985) , and the new start mutation that identified the CDC60 gene was similarly obtained (BEDARD, JOHNSTON and SINGER 198 1) . Yet another selection scheme designed to isolate mutant cells blocked at start without regard for growth abilities led to the identification of the cdc62-1, cdc64-1 and cdc63-1 (prtl-63; HANIC-JOYCE, SINGER andJoHNsToN 1987) start mutations (BEDARD, JOHNSTON and SINGER 1981) . The gradient enrichment scheme described here thus augments procedures available for mutant isolation by making use of another characteristic of cdc mutants, that of cell enlargement.
Two of the mutations described here prevented mutant cells from forming zygotes efficiently at the nonpermissive temperature (Table 4) , despite the maintenance of significant (though decreased) levels of biosynthetic activity (Figure 2 ). In comparison, the p r t l -6 3 start mutation also decreases protein and RNA synthesis to levels similar to those in the cdc65-1 and cdc67-1 mutant cells (BEDARD, JOHNSTON and SINGER 198 I), but start-arrested p r t l -6 3 mutant cells mate well ( BEDARD et al. 1984) . Thus the degree of impairment of global biosynthetic activity in cdc65-1 and cdc67-1 mutant cells seems insufficient to account for the impaired zygote formation. By analogy with other genes that encode proteins necessary for start and for karyogamy during conjugation (DUTCHER and HARTWELL 1982), perhaps the CDC65 and CDC67 genes encode gene products required for cell fusion as well as for start.
A striking finding from this study is the underrepresentation of previously identified genes that affect start. In particular, mutations in the CDC28, CDC36, CDC37 or CDC39 genes were not obtained, even though the basic tenet (conjugational proficiency) of the selection scheme used by Reed (1 980) to obtain start mutations in those genes is contingent on the criterion used here (continued biosynthetic activity leading to cell enlargement). This finding that related selection schemes identify nonoverlapping sets of start mutations suggests that the catalog of genes that affect start relatively directly may be larger than expected. 
